WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that, effective January 19, 2026, Paul Mann, the founder and Executive Chairman of ASP Isotopes, will resume his role as the Company’s Chief Executive Officer and continue as Executive Chairman. On September 29, 2025, it was announced ...

Company Overview - ASP Isotopes Inc. is a development stage advanced materials company focused on producing isotopes for various industries using proprietary technology known as the Aerodynamic Separation Process (ASP technology) [3] - The company's initial focus is on highly enriched isotopes for the healthcare and technology sectors, with plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [3] - ASP Isotopes has isotope enrichment facilities located in Pretoria, South Africa, dedicated to enriching light isotopes [3] Recent Developments - ASP Isotopes Inc. announced that its subsidiary, Quantum Leap Energy LLC, has confidentially submitted a draft registration statement on Form S-1 to the SEC for a proposed initial public offering of QLE's Class A common stock [1] - The number of shares to be offered and the price range for the proposed offering have not yet been determined, and the IPO is subject to SEC review and market conditions [1]

Core Viewpoint - ASP Isotopes Inc. is hosting an Investor Access Event in South Africa from June 16-18, 2025, to enhance transparency and communication with stakeholders [1][3]. Event Details - The event will include scientific sessions and plant tours, allowing investors to see the company's enrichment production plants and meet the management and scientific teams [4][5]. - An additional day for visiting the Renergen Virginia Gas Project is available on June 19, 2025, subject to availability [2]. Company Progress - As of April 2025, ASP Isotopes is commercially enriching Carbon-14 and Silicon-28, with the Ytterbium-176 plant producing commercial samples [4]. - The company has hosted over 60 investors and corporate clients in 2024 and a successful event in January 2025 with 27 investors from three continents [3]. Technology and Market Demand - ASP Isotopes employs proprietary Aerodynamic Separation Process technology for isotope production, focusing on healthcare and technology industries [6]. - There is a growing demand for isotopes such as Silicon-28 for quantum computing and various isotopes for emerging healthcare applications and green energy [7][8].